MOTS-c: Mitochondrial-Derived Peptide Research Overview

MOTS-c is part of a class of peptides known as mitochondrial-derived peptides (MDPs), which are encoded within the mitochondrial genome rather than the nuclear genome. This makes them unique among the peptides studied in research labs, since the vast majority of known peptides are nuclear-encoded.^[1]

MOTS-c was first characterized by Lee and colleagues in 2015, who identified the 16-amino acid sequence within the 12S ribosomal RNA gene of mitochondrial DNA and described its translation, cellular localization, and metabolic signaling activity in preclinical mouse models.^[1]

MOTS-c is studied as a model compound for investigating mitochondrial-nuclear communication, since the peptide is encoded in mitochondria but exerts its proposed signaling effects on nuclear gene expression and on cellular metabolism more broadly.

MOTS-c has the following primary structure:

• Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (16 residues)

• Molecular weight: approximately 2,174 Da

• Encoding: Mitochondrial 12S rRNA gene (MT-RNR1), small open reading frame

• Form: Lyophilized solid for research applications

The 16-residue sequence contains a mix of polar and nonpolar amino acids without disulfide-bond-forming cysteines. The compact size and balanced charge distribution contribute to defined behavior in vitro, making it tractable for cell-based and in vivo preclinical studies.

Synthetic MOTS-c is produced by solid-phase peptide synthesis (SPPS) to match the endogenous sequence. Research-grade material is supplied as a lyophilized powder under inert atmosphere to preserve integrity.

Preclinical investigations have examined several proposed signaling activities of MOTS-c. These remain under active study and are not collectively established as therapeutic mechanisms; they are reported as research findings in controlled experimental systems.

The most extensively studied proposed activity of MOTS-c involves engagement with the AMP-activated protein kinase (AMPK) signaling pathway, a central regulator of cellular energy homeostasis. Preclinical studies have reported MOTS-c-associated AMPK pathway activation in skeletal muscle cell lines and mouse models.^[1][2]

A separate body of research has examined MOTS-c interactions with the folate-methionine one-carbon metabolic pathway, which connects to methylation reactions throughout the cell. These studies are conducted in cell culture systems with metabolomic profiling endpoints.^[1]

MOTS-c's mitochondrial origin combined with reported effects on nuclear gene expression makes it a tool compound for studying retrograde mitochondrial-to-nuclear signaling. Researchers have used the peptide in cell-based systems to probe how mitochondrial state communicates with nuclear transcriptional programs.^[3]

Published MOTS-c research spans several distinct preclinical domains, summarized below.

A subset of MOTS-c literature examines parallels between MOTS-c administration and physical exercise in rodent models. Endpoints include measures of skeletal muscle gene expression, mitochondrial biogenesis markers, and metabolic substrate utilization in animal studies.^[4]

Endogenous MOTS-c levels have been reported to decline with age in animal models, prompting research interest in whether exogenous MOTS-c administration in preclinical aging models affects metabolic phenotypes. These studies are exploratory and do not constitute clinical evidence.^[5]

Preclinical studies in rodent models of insulin resistance have examined MOTS-c effects on glucose tolerance, insulin sensitivity markers, and tissue-specific glucose uptake.^[2]

MOTS-c is supplied as a lyophilized powder. Standard handling practices for synthetic peptides apply.

Lyophilized MOTS-c is stored at minus 20 degrees Celsius or colder for long-term preservation. Brief storage at 4 degrees Celsius is acceptable for material in active use. Reconstituted solution is used within several weeks and stored at 4 degrees Celsius.

Bacteriostatic water (0.9 percent benzyl alcohol) is the standard reconstitution solvent for research preparations. Reconstitution is performed by directing the solvent down the inner vial wall and swirling gently rather than shaking to minimize foaming.

Quality is verified by HPLC for purity (greater than or equal to 99 percent), mass spectrometry for identity confirmation matching the expected 16-amino acid sequence, and endotoxin testing. Every batch of Instant Peptides MOTS-c ships with a full Certificate of Analysis.

Instant Peptides supplies MOTS-c as a synthetic lyophilized reference compound in 10mg and 40mg vials. Material is supplied to qualified research professionals and scientific institutions. Not for human or animal consumption, diagnostic, or therapeutic use.

View the product page for current pricing and the Certificate of Analysis for the active batch.